Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Targeting NF-κB in glioblastoma: A therapeutic approach.

Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma IM.

Sci Adv. 2016 Jan 8;2(1):e1501292. doi: 10.1126/sciadv.1501292. eCollection 2016 Jan.


Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.

Soda Y, Myskiw C, Rommel A, Verma IM.

J Mol Med (Berl). 2013 Apr;91(4):439-48. doi: 10.1007/s00109-013-1019-z. Epub 2013 Mar 20. Review.


Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.

Myskiw C, Arsenio J, Hammett C, van Bruggen R, Deschambault Y, Beausoleil N, Babiuk S, Cao J.

J Virol. 2011 Dec;85(23):12280-91. doi: 10.1128/JVI.05505-11. Epub 2011 Sep 14.


RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis.

Myskiw C, Arsenio J, Booy EP, Hammett C, Deschambault Y, Gibson SB, Cao J.

Virology. 2011 May 10;413(2):183-93. doi: 10.1016/j.virol.2011.01.034. Epub 2011 Feb 26.


Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.

Myskiw C, Piper J, Huzarewich R, Booth TF, Cao J, He R.

Antiviral Res. 2010 Dec;88(3):304-10. doi: 10.1016/j.antiviral.2010.10.001. Epub 2010 Oct 15.


Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways.

Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J.

J Virol. 2009 Jul;83(13):6757-68. doi: 10.1128/JVI.02570-08. Epub 2009 Apr 15.


Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.

Myskiw C, Deschambault Y, Jefferies K, He R, Cao J.

J Virol. 2007 Mar;81(6):3027-32. Epub 2006 Dec 27.

Supplemental Content

Loading ...
Support Center